National and Kapodistrian University of Athens
Αξιολόγηση της σχέσης πόνου, επιπέδων σιαλικής α-αμυλάσης και ποιότητας ζωής ασθενών με καρκίνο κεφαλής-τραχήλου, που υποβάλλονται σε ακτινοθεραπεία / χημειοακτινοθεραπεία
Abstract
dc:descriptionIntroduction: Improvements in head and neck cancer treatment have increased the survival rateof head and neck cancer patients but therapeutic interventions may induce further challenges.Head and neck cancer treatment can damage not only cancer cells but also healthy cells, tissuesand nerves. One of the most common and debilitating consequences of treatment in patientswith head and neck cancer is oral pain. Oral pain leads to increased use of feeding tubes andopioid consumption, hospitalization and treatment discontinuation. Painful oral mucositis is acomplication of radiotherapy. Chewing, swallowing and talking, exacerbate pain in patients withoral mucositis. Pain due to mucositis is considered one of the most devastating complicationsand may increase medical costs. Treatment related pain in patients with head and neck cancermay be nociceptive and / or neuropathic.Salivary α-amylase levels may change according to pain intensity changes. Amylase levels couldbe an objective indicator of pain. Also, during radiotherapy, the patients’ quality of life decreasesdue to pain and the general functional disability that pain causes. The possibility of the need fordifferentiation or discontinuation of treatment and for prolonged hospitalization, increases paineffects in the course of treatment and patients' life.Purpose: The purpose of this study was to study the relationship between pain and salivary αamylase levels as well as the quality of life of these patients, and, secondary to investigate thecharacteristics of pain (nociceptive and / or neuropathic pain) felt by patients with head and neckcancer during radiotherapy.Patients & Method: The study included outpatients with head and neck cancer who were goingto receive radiotherapy, with or without chemotherapy, and were referred to the Unit of CancerPatient’s Management of the Department of Oral Pathology and Hospital Dentistry of theNational and Kapodistrian University of Athens for preparation and supportive care of the oralcavity during antineoplastic therapy. Patients underwent a detailed clinical examination of theoral cavity, an X-ray examination was recommended and they were given detailed oral hygieneinstructions.In the first visit, prior to treatment, a thorough medical and dental history was taken and patients’gender, age, place of residence, level of education and marital status were recorded. Patientswere asked to fulfil the EORTC QLQ-C30 (European Organization for Research and Treatment ofCancer Quality of Life Questionnaire-Core 30) version 3.0 and the EORTC QLQ-H&N35 (EORTCQuality of Life Questionnaire Head and Neck Module) questionnaires. At each subsequent visit,a detailed clinical examination was performed, where pain, mucositis and xerostomia, painmedication consumption and presence of herpes and/or fungal infection were recorded. Salivasampling and quality of life questionnaires were administered at first before radiotherapyinitiation and then between the 5th week of radiotherapy and up to 2 weeks after the end ofradiotherapy, as severe pain occurs at about the 5th week of radiotherapy and decreases about2-4 weeks after the end of radiotherapy. The numeric rating scale (NRS) was used to assess pain.Mucositis was assessed using the five-point (0-IV) European Organization for Research andTreatment of Cancer / Radiation Therapy Oncology Group (EORTC / RTOG) scale. The NRS scale was also used for the evaluation of xerostomia as there was no validated assessment scale forxerostomia in Greek language. If patients reported NRS≥5 pain, the DN4 (Douleur Neuropathique4) questionnaire for neuropathic pain was also used, only once. Analysis of the samples andquantification of salivary α-amylase levels was performed using the 2-Chloro-NPG3-SubstratePhotometric method.Results: The study sample consists of 40 patients, 33 men and 7 women, with a mean age of 64.2years. More specifically, the average age of men and women was 63.7 and 66.6 years accordingly.Oral / oropharyngeal cancer had 45% of patients, laryngeal cancer 22.5%, nasal / nasopharyngealcancer 7.5% and parotid cancer 7.5%.Patients included in the study did not report oral pain at the time of enrollment. Duringradiotherapy, 87.5% of patients reported pain (of varying severity) and 40% reported severe painduring their 2nd evaluation. Severe pain was reported by 61.1% of the patients with oral /oropharyngeal cancer and pain only while swallowing was reported by 55.6% of patients withlaryngeal cancer. Only 57.7% of patients who reported moderate or severe pain received painmedication and 3.85% of patients with neuropathic pain received adjuvant medication(pregabalin).Clinical signs of fungal or herpetic infection had 12.5% and 15% of the patients accordingly.Among the patients who answered the DN4 questionnaire, 65.38% reported at least onedescriptive characteristic of neuropathic pain and 19.23% had a positive score for neuropathicpain. The most common descriptive terms for neuropathic pain were "burning" (9/26, 34.62%),"electric shocks" (8/26, 30.77%) and "pins-and-needles" (8/26, 30.77%). A strong positivecorrelation was observed between the DN4 scale and pain (p = 0.001), mucositis (p <0.001) andxerostomia (p = 0.002). No correlation was observed between the intensity of pain and mucositis(p = 0.119).There was a statistically significant decrease in the mean score of the sub-scale "Overall health /quality of life" of the questionnaire "QLQ-C30", during the 2nd evaluation of patients in relationto the values before radiotherapy (p <0.001). The mean score of the subscale "Functional Scales",of the questionnaire "QLQ-C30", was found statistically significantly higher in the 2nd evaluationof patients compared to the score before radiotherapy (p <0.001). The mean score of the"Symptom Scales" sub-scale of the "QLQ-C30" questionnaire was found to be statisticallysignificantly higher in the 2nd evaluation of patients in relation to the score before the initiationof radiotherapy (p <0.001). There was no statistically significant correlation between the changesin the scores of the subscales of the questionnaire "QLQ-C30" and pain intensity. The mean scoreof the "QLQ-H&N35" questionnaire before radiotherapy was found, statistically significantly,lower than the one during the 2nd evaluation of patients (p <0.001). The correlation betweenthe level of pain reported by the patients and the change of the "QLQ-H&N35" questionnairescore was observed to be on the margin of statistical significance (p = 0.054).The mean value of salivary α-amylase in the 2nd evaluation was found, statistically significantly,lower than the mean value of salivary α-amylase before radiotherapy (p = 0.006). No statisticallysignificant results were found between the level of pain and the change in salivary α-amylaselevels. There was no statistically significant correlation between the mean radiation dosereceived by parotids and submandibular glands and the change in salivary α-amylase levels. Astatistically significant correlation was found between the degree of xerostomia and the decreasein salivary α-amylase levels (p = 0.002).Discussion - Conclusions: Patients with head and neck cancer undergoing radiotherapy reportpain related to radiation induced toxicity even in the IMRT (intensity modulated radiationtherapy) era. During radiotherapy, 87.5% of patients reported pain (of varying severity) and 40%reported severe pain. Among patients with oral or oropharyngeal cancer 68.75% developedsevere pain, which is related to the extentance of the radiation field. Pain only while swallowing(odynophagia) was reported by 15% of patients, most of whom had laryngeal cancer. This findingis also related to the extentance of the radiation field. The proportion of patients with pain onlywhile swallowing is similar to the findings of other researchers who reported intermittent pain.Odynophagia should be considered a form of breakthrough pain and should be treatedaccordingly. Almost half of the patients with moderate or severe pain during radiotherapy didnot receive pain medication. This finding suggests the need for better evaluation and treatmentof patients' pain. No correlation was found between the reported pain and the severity ofmucositis. This may be related to different levels of patients’ pain tolerance, as they havedifferent pain thresholds in similar stimuli.The low rates, compared to the literature, of symptoms of fungal and herpes infection could berelated to the oral hygiene protocol given to patients, which includes frequent rinsing with warmchamomile for cleansing and moisturizing of oral cavity; chamomile shows fungicidal activityagainst Candida albicans. They could also be related to the more precise targeting of radiation asnewer RT modalities, such as IMRT, are increasingly used. Differential diagnosis of fungal andherpes infection and mucositis is necessary as patients with fungal infections may report "burningpain" in the oral cavity while patients with herpes infection may report severe pain that is notrelated to the presence of oral mucositis.The statistically significant reduction found in salivary α-amylase levels, is consistent with mostof the existing studies. No correlation was found between salivary α-amylase levels and the levelsof pain reported by patients, asthe direct damage of the radiation to the salivary glands probablyoutweighs the autonomic nervous system effects on them. The correlation between the decreasein salivary α-amylase levels and xerostomia could indicate the possibility of using salivary αamylase levels as an indicator of the radiation damage on salivary glands, but the results of thecorrelation of the reduction of salivary α-amylase levels with the mean dose received by theparotids or submandibular salivary glands were not statistically significant. A larger sample ofpatients may be needed for statistically significant results.There was a statistically significant decrease in the quality of life of patients after the 5th weekof radiotherapy compared to the quality of life before radiotherapy. No statistically significantresult was found in the correlation of patients' pain levels with the changes in quality of life levelsin the overall scores of the QLQ-C30 questionnaire subscales. The correlation between the levelof pain and the QLQ-H&N35 questionnaire scores was found to be on the margin of statisticalsignificance. The literature reports a statistically significant correlation between pain and qualityof life levels. Probably the number of patients who participated in thisstudy was not large enoughin order to show a statistically significant correlation, as well as to further analyze the individualsections of the sub-scales of the quality of life questionnaires in relation to pain.A positive result for neuropathic pain was found in 19.23% of patients with moderate or severepain which is similar to other studies’ results. Statistically significant differences in the descriptivecharacteristics of neuropathic pain between patients with a positive and negative result in theDN4 questionnaire were present in "electric shocks", "tingling", "pins and needles" and"numbness". This may indicate that clinicians may suspect the presence of NP when patientsreport certain pain characteristics, such as “electric shocks”. A statistically significant correlationwas observed between the results of the DN4 questionnaire and the intensity of pain as well asbetween the severity of the mucositis and the results of the DN4 questionnaire. These findingscould be related to the pathways related to the development of neuropathic pain due to theextended exposure to the noxious stimuli (severe oral mucositis), where cytokines are releasedfrom microglia causing central sensitization due to severe pain.The small sample of the study is a limitation that may not allow the findings to be generalizedbeyond patients with similar characteristics to those included in the study. Studies with a largernumber of patients are needed in order to better investigate the correlations between theparameters of the present study. The relationship between the development of neuropathic painand the presence of fungal and / or herpes infections in the oral cavity, and, the effect ofneuropathic pain on patients' quality of life could also be investigated.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kouri, Maria
- Κουρή, Μαρία
Subjects
dc:subject × 18- Καρκίνος κεφαλής-τραχήλου
- Ακτινοθεραπεία
- Χημειοακτινοθεραπεία
- Πόνος
- Σιαλική α-αμυλάση
- Ποιότητα ζωής
- Head-neck cancer
- Radiotherapy
- Chemoradiotherapy
- Pain
- Salivary α-amylase
- Quality of life
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες υγείας, άλλοι τομείς
- Health Sciences
- Medical and Health Sciences
- Health sciences, miscellaneous
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/51199